Literature DB >> 20689673

Microwave-assisted Organic Synthesis of a High-affinity Pyrazolo-pyrimidinyl TSPO Ligand.

Dewei Tang1, Jason R Buck, Matthew R Hight, H Charles Manning.   

Abstract

We herein report a dramatically improved total synthesis of the high-affinity translocator protein (TSPO) ligand DPA-714, featuring microwave-assisted organic synthesis (MAOS). Compared with previously described approaches, our novel MAOS method dramatically reduces overall reaction time without adversely effecting reaction yields. We envision that the described MAOS protocol may be suitably applied to high-throughput, diversity-oriented synthesis of novel compounds based on the pyrazolo-pyrimidinyl scaffold. Such an approach could accelerate the development of focused libraries of novel TSPO ligands with potential for future development as molecular imaging and therapeutic agents.

Entities:  

Year:  2010        PMID: 20689673      PMCID: PMC2913893          DOI: 10.1016/j.tetlet.2010.06.074

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

1.  2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands.

Authors:  S Selleri; F Bruni; C Costagli; A Costanzo; G Guerrini; G Ciciani; B Costa; C Martini
Journal:  Bioorg Med Chem       Date:  2001-10       Impact factor: 3.641

2.  Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer.

Authors:  Kerstin Maaser; Patricia Grabowski; Andreas P Sutter; Michael Höpfner; Hans-Dieter Foss; Harald Stein; Gerd Berger; Moshe Gavish; Martin Zeitz; Hans Scherübl
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

3.  Facile, efficient conjugation of a trifunctional lanthanide chelate to a peripheral benzodiazepine receptor ligand.

Authors:  H Charles Manning; Timothy Goebel; John N Marx; Darryl J Bornhop
Journal:  Org Lett       Date:  2002-04-04       Impact factor: 6.005

Review 4.  Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis.

Authors:  V Papadopoulos; H Amri; N Boujrad; C Cascio; M Culty; M Garnier; M Hardwick; H Li; B Vidic; A S Brown; J L Reversa; J M Bernassau; K Drieu
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

5.  Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand.

Authors:  Michelle L James; Roger R Fulton; David J Henderson; Stefan Eberl; Steven R Meikle; Sally Thomson; Robin D Allan; Frederic Dolle; Michael J Fulham; Michael Kassiou
Journal:  Bioorg Med Chem       Date:  2005-07-20       Impact factor: 3.641

6.  Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread.

Authors:  Kerstin Maaser; Patricia Grabowski; Yelda Oezdem; Antje Krahn; Bernhard Heine; Harald Stein; Heinz Buhr; Martin Zeitz; Hans Scherübl
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

Review 7.  The peripheral benzodiazepine receptor: a promising therapeutic drug target.

Authors:  Sylvaine Galiegue; Norbert Tinel; Pierre Casellas
Journal:  Curr Med Chem       Date:  2003-08       Impact factor: 4.530

8.  DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.

Authors:  Michelle L James; Roger R Fulton; Johnny Vercoullie; David J Henderson; Lucette Garreau; Sylvie Chalon; Frederic Dolle; Barbara Costa; Silvia Selleri; Denis Guilloteau; Michael Kassiou
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

9.  Targeted molecular imaging agents for cellular-scale bimodal imaging.

Authors:  H Charles Manning; Timothy Goebel; Reid C Thompson; Ronald R Price; Haakil Lee; Darryl J Bornhop
Journal:  Bioconjug Chem       Date:  2004 Nov-Dec       Impact factor: 4.774

10.  [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis.

Authors:  Janine Doorduin; Hans C Klein; Rudi A Dierckx; Michelle James; Michael Kassiou; Erik F J de Vries
Journal:  Mol Imaging Biol       Date:  2009-03-28       Impact factor: 3.488

View more
  6 in total

1.  New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO.

Authors:  Jun Li; Michael L Schulte; Michael L Nickels; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2016-06-16       Impact factor: 2.823

2.  Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline.

Authors:  Jason R Buck; Eliot T McKinley; Matthew R Hight; Allie Fu; Dewei Tang; Ralph Adam Smith; Mohammed Noor Tantawy; Todd E Peterson; Daniel Colvin; Mohammed Sib Ansari; Ronald M Baldwin; Ping Zhao; Saffet Guleryuz; H Charles Manning
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057

3.  Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.

Authors:  Dewei Tang; Matthew R Hight; Eliot T McKinley; Allie Fu; Jason R Buck; R Adam Smith; Mohammed Noor Tantawy; Todd E Peterson; Daniel C Colvin; M Sib Ansari; Michael Nickels; H Charles Manning
Journal:  J Nucl Med       Date:  2012-01-17       Impact factor: 10.057

4.  Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.

Authors:  Dewei Tang; Eliot T McKinley; Matthew R Hight; Md Imam Uddin; Joel M Harp; Allie Fu; Michael L Nickels; Jason R Buck; H Charles Manning
Journal:  J Med Chem       Date:  2013-04-03       Impact factor: 7.446

5.  Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma.

Authors:  Dewei Tang; Jun Li; Michael L Nickels; Gang Huang; Allison S Cohen; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

6.  Rapid, Microwave-Assisted Organic Synthesis of Selective (V600E)BRAF Inhibitors for Preclinical Cancer Research.

Authors:  Jason R Buck; Sam Saleh; Md Imam Uddin; H Charles Manning
Journal:  Tetrahedron Lett       Date:  2012-06-06       Impact factor: 2.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.